Bone mass evolution after renal transplantation

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Ischemic heart disease after renal transplantation

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Marlies Noordzij, Kitty J. Jager Kidney International

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

Membranous nephropathy: When and how to treat

Kidney transplantation in a low-resource setting: Nigeria experience

Progression of renal failure and hypertensive nephrosclerosis

Volume 63, Pages S88-S90 (June 2003)

Volume 77, Issue 1, Pages 6-8 (January 2010)

Volume 71, Issue 8, Pages (April 2007)

Long-neglected stent in a transplanted kidney

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Volume 66, Pages S13-S17 (September 2004)

Volume 66, Issue 5, Pages (November 2004)

Comorbidity and confounding in end-stage renal disease

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 87, Issue 2, Pages (February 2015)

Volume 95, Issue 2, Pages (February 2019)

Volume 77, Pages S8-S11 (March 2010)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Volume 73, Issue 8, Pages (April 2008)

Volume 59, Issue 4, Pages (April 2001)

Volume 76, Issue 5, Pages (September 2009)

Fructose intake as a risk factor for kidney stone disease

Kidney Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Therapeutic Dilemma (or Not)? Marina Noris, PhD, Piero Ruggenenti, MD,

Arterial function after successful renal transplantation

Volume 54, Issue 3, Pages (September 1998)

P. Urena Torres, G. Friedlander, M.C. de Vernejoul, C. Silve, D. Prié

The third World Kidney Day: Looking back and thinking forward

Urethral steinstrasse in renal transplantation

Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation? Lionel Rostaing, Nassim Kamar Kidney International

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

J.M. van den Akker, J.F.M. Wetzels, A.J. Hoitsma Kidney International

Racial disparities in access to transplantation: a tough nut to crack

Volume 85, Issue 1, Pages 3-4 (January 2014)

Volume 64, Issue 3, Pages (September 2003)

Counteracting progression of renal disease: A look into the future

Nephrology Crossword: Glomerulonephritis

What can be learned using microarrays?

Volume 56, Pages S235-S237 (July 1999)

A man with a hole in his penis

Fibrosis and renal aging

Volume 73, Issue 9, Pages (May 2008)

Mediterranean diets: are they practical in the Western world?

Endothelin antagonists in renal disease

Long-term survival in renal transplant recipients with graft function

Volume 55, Issue 5, Pages (May 1999)

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Organ transplantation goes to the movies

Does equal care give equal outcomes?

Volume 83, Issue 4, Pages (April 2013)

Volume 63, Issue 6, Pages (June 2003)

Volume 69, Issue 10, Pages (May 2006)

Volume 56, Issue 2, Pages (August 1999)

Is complement a target for therapy in renal disease?

Volume 70, Issue 5, Pages (September 2006)

Quiz Page November 2005 American Journal of Kidney Diseases

Ischemic heart disease after renal transplantation

The international realities of live donor kidney transplantation

Volume 69, Issue 8, Pages (April 2006)

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

Volume 57, Issue 2, Pages (October 2000)

Ronen Levi, Justin Silver Kidney International

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Bone mass evolution after renal transplantation E. Goffin, J.P. Devogelaer, G. Depresseux, C. van Ypersele de Strihou Kidney International Volume 59, Issue 4, Pages 1594-1595 (April 2001) DOI: 10.1046/j.1523-1755.2001.00661.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Bone mineral density measured by dual energy x-ray absorptiometry at 12 months post-transplantation. It is expressed as the percentage of the value obtained at the time of transplantation. It falls significantly in all the evaluated sites. Immunosuppression includes cyclosporine, steroids (maintenance dose of 7.5 mg/day after 120 days) and either mycophenolate mofetil or azathioprine. (*P < 0.05, **P < 0.01, ***P < 0.001). Kidney International 2001 59, 1594-1595DOI: (10.1046/j.1523-1755.2001.00661.x) Copyright © 2001 International Society of Nephrology Terms and Conditions